ロード中...
Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemia
CD19 immunotherapies based on T cells opened new avenues in the treatment of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However, Fc engineered CD19 antibodies may also bear great potential. In light of recent preclinical and clinical data, perspectives of such antibodies desi...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136853/ https://ncbi.nlm.nih.gov/pubmed/30221037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1448331 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|